Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Roche Holding AG | 0.89% | $91.46M | CHF252.45B | 36.57% | 73 Outperform | |
| Shell | 0.83% | $85.77M | $209.04B | 10.96% | 78 Outperform | |
| HSBC Holdings | 0.72% | $74.24M | $234.15B | 48.33% | 78 Outperform | |
| ASML Holding | 0.71% | $72.65M | $366.73B | 41.21% | 81 Outperform | |
| Novartis | 0.66% | $67.56M | $242.12B | 22.96% | 80 Outperform | |
| Rheinmetall | 0.61% | $62.87M | €69.72B | 138.75% | 58 Neutral | |
| SAFRAN SA | 0.60% | $61.97M | €120.61B | 32.90% | 67 Neutral | |
| Celestica | 0.58% | $59.34M | $32.22B | 227.17% | 74 Outperform | |
| TotalEnergies | 0.53% | $54.68M | $138.98B | 10.97% | 77 Outperform | |
| Toyota Motor | 0.53% | $54.34M | $257.57B | 12.39% | 81 Outperform |